Clinical Trial Update: A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of JNT-517 in adolescents with phenylketonuria (PKU), sponsored by Otsuka Pharmaceutical Development & Comm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• JNT-517

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Phenylketonuria (PKU) | Phase 2 | Status: RECRUITING